Log in to search using one of your social media accounts:

 

TSRI scientists find key proteins control risk of osteoarthritis during aging
(Scripps Research Institute) A study from scientists at The Scripps Research Institute (TSRI) explains why the risk of osteoarthritis increases as we age and offers a potential avenue for developing new therapies to maintain healthy joints. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2018 Category: International Medicine & Public Health Source Type: news

Orthofix launches RCStim rotator cuff repair trial
Orthofix (NSDQ:OFIX) said today it launched a study looking to evaluate the use of pulsed electromagnetic field technology with the company’s RCStim device as adjunctive treatment to the surgical repair of rotator cuff tears. The 538-patient study, which has begun enrollment, will evaluate the safety and effectiveness of PEMF technology designed to promote bone growth and whether it can reduce the rate of repaired tendons being subsequently torn, as well as overall improvement in patient outcomes. “Arthroscopic repair of rotator cuff tears can improve pain and functional use of the shoulder but a continuin...
Source: Mass Device - February 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Orthopedics Orthofix Source Type: news

£ 1.6M study will determine how bone size, shape and structure contributes towards arthritis and other musculoskeletal diseases
How the size, shape and structure of bones and joints contribute towards the development of common age-related diseases such as osteoarthritis and osteoporosis will be investigated by an international research team thanks to a £ 1.6 million Wellcome Trust award. (Source: University of Bristol news)
Source: University of Bristol news - February 12, 2018 Category: Universities & Medical Training Tags: Research, Grants and Awards, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Faculty of Health Sciences, Centre for Applied Anatomy; Press Release Source Type: news

£ 1.6 million study will determine how bone size, shape and structure contributes towards arthritis and other musculoskeletal diseases
How the size, shape and structure of bones and joints contribute towards the development of common age-related diseases such as osteoarthritis and osteoporosis will be investigated by an international research team thanks to a £ 1.6 million Wellcome Trust award. (Source: University of Bristol news)
Source: University of Bristol news - February 12, 2018 Category: Universities & Medical Training Tags: Research, Grants and Awards, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Faculty of Health Sciences, Centre for Applied Anatomy; Press Release Source Type: news

Preoperative KOOS and SF-36 scores linked to risk of symptomatic knee OA after ACL reconstruction
A study published online in The American Journal of Sports Medicine suggests that lower preoperative Knee injury and Osteoarthritis Outcome Score (KOOS) and SF-36 scores may be linked to increased risk of symptomatic knee osteoarthritis (OA) after anterior cruciate ligament (ACL) reconstruction.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - February 10, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Molecular influence of anterior cruciate ligament tear remnants on chondrocytes: a biologic connection between injury and osteoarthritis - Chinzei N, Brophy RH, Duan X, Cai L, Nunley RM, Sandell LJ, Rai MF.
OBJECTIVE: Anterior cruciate ligament (ACL) injury initiates a cascade of events often leading to osteoarthritis. ACL reconstruction does not alter the course of osteoarthritis, suggesting that heightened osteoarthritis risk is likely due to factors in add... (Source: SafetyLit)
Source: SafetyLit - February 5, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Anika collabs to develop injectable stem cell therapy for osteoarthritis
Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis. As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials. Get the full story at our sister site, Drug Delivery Business News. The post Anika collabs to develop injectable stem cell therapy for osteoarthritis appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Orthopedics Pharmaceuticals Research & Development Stem Cells Wall Street Beat Anika Therapeutics Inc. University of Liverpool Source Type: news

Best supplements: Arthritis joint pain eased with these 24p a day capsules
BEST supplements for arthritis pain could help to eradicate joint pain and inflammation. These cheap capsules could help to get rid of osteoarthritis knee pain. (Source: Daily Express - Health)
Source: Daily Express - Health - January 25, 2018 Category: Consumer Health News Source Type: news

The impact of lower total knee replacement rates in black Americans
(Wiley) The impact of lower total knee replacement rates in black Americans.It's known that racial minorities in the United States undergo fewer total knee replacements (TKRs) for knee osteoarthritis, but it's unclear how this affects their quality of life. A new study published in Arthritis Care& Research indicates that, on a population level, black Americans lose 72,000 quality-adjusted life years (QALYs) due to racial disparities in the lower rate of TKRs offered and acceptance, and higher rates of complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2018 Category: International Medicine & Public Health Source Type: news

Incidence and risk factors for falls in women with end-stage hip osteoarthritis - Ikutomo H, Nagai K, Tagomori K, Miura N, Nakagawa N, Masuhara K.
BACKGROUND AND PURPOSE: Fall-induced injuries and resulting deaths are a serious health problem among older adults. The most common risk factors for falls in older adults are muscle weakness, gait deficiencies, and balance deficits. Patients with end-stage... (Source: SafetyLit)
Source: SafetyLit - January 22, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

ACL and meniscal injuries increase the risk of primary total knee replacement for osteoarthritis: a matched case-control study using the Clinical Practice Research Datalink (CPRD) - Khan T, Alvand A, Prieto-Alhambra D, Culliford DJ, Judge A, Jackson WF, Scammell BE, Arden NK, Price AJ.
OBJECTIVES: The aim of this study was to investigate whether ACL injury (ACLi) or meniscal injury increases the risk of end-stage osteoarthritis (OA) resulting in total knee replacement (TKR). METHODS: A matched case-control study of all TKRs perfo... (Source: SafetyLit)
Source: SafetyLit - January 17, 2018 Category: International Medicine & Public Health Tags: Recreational and Sports Issues Source Type: news

Osteoarthritis 'could be re-categorised as two distinct groups of disease'
Osteoarthritis could be treated more effectively in the future by dividing patients into two distinct disease groups, according to new research. TheArthritis Research UK-funded study, carried out by the University of Manchester, has discovered that the current definition of osteoarthritis may actually encompass two separate groups with different disease activity patterns, and that developing new treatments for both versions may be more effective than the current one-size-fits-all approach. Two different patterns of disease activity Published in the Annals of the Rheumatic Diseases, the research involved a mathematical anal...
Source: Arthritis Research UK - January 17, 2018 Category: Rheumatology Source Type: news

6th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD)
The 6th BMJD Congress will address the most burning questions in the field of Rheumatoid Arthritis, Inflammatory Arthritis, Osteoarthritis, Spondyloarthropathy, Lupus, and more.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - January 11, 2018 Category: Orthopaedics Tags: Featured Meetings Events Source Type: news

Every £1 invested in medical research delivers a return equivalent to 25p every year, forever
This study shows that funding research into these conditions not only delivers direct health benefits to patients, it is also hugely beneficial to the UK economy, helping to lay the foundations for a healthier, wealthier future.“This report supports previous findings that investing in biomedical research delivers an annual return of about 25 pence per pound in perpetuity, offering an indisputable economic benefit. This new figure ably illustrates why scientific research has earnt its place at the heart of a modern industrial strategy.”Dr Louise Wood, Director of Science, Research and Evidence, Department of Hea...
Source: Arthritis Research UK - January 10, 2018 Category: Rheumatology Source Type: news

Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system
Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system. The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that don’t compromise fixation, the Warsaw, Ind.-based company said. “The Sidus stem-free shoulder system offers a novel approach to total shoulder arthroplasty requiring minimal bone resection. The Sidus system is designed to reduce pa...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance zimmerbiomet Source Type: news

Will Sidus Take a Load off Zimmer & #039;s Shoulders?
Zimmer Biomet didn't have the best year in 2017, but the company's first FDA clearance of 2018 could be a sign of better things to come for the Warsaw, IN-based orthopedic device maker. FDA cleared the Sidus Stem-Free Shoulder system as a total shoulder arthroplasty solution for patients with good bone stock that have either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head, or who had previous surgeries of the shoulder that do not compromise the fixation. The Sidus system is designed to anatomically restore a patient's anatomy, preserve bone stock, and allow for improved...
Source: MDDI - January 4, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news

Effects of different foot progression angles and platform settings on postural stability and fall risk in healthy and medial knee osteoarthritic adults - Khan SJ, Khan SS, Usman J, Mokhtar AH, Abu Osman NA.
This study aims to investigate the effects of varying toe angles at different platform settings on Overall Stability Index of postural stability and fall risk using Biodex Balance System in healthy participants and medial knee osteoarthritis patients. Biod... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Medical News Today: Knee osteoarthritis: What's the best weight loss plan?
Weight loss is known to reduce osteoarthritis symptoms and signs. But which weight loss regimen is best? New research investigates. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 29, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Zimmer Biomet touts pilot data for nStride knee injection
Zimmer Biomet (NYSE:ZBH) last week touted data from a pilot study of its nStride autologous protein solutions kit for treating osteoarthritis of the knee. The nStride APS kit allows surgeons to concentrate anti-inflammatory cytokines and growth factors from a patient’s blood sample, which are then injected into the knee. The 46-patient Progress II study randomized subjects to either a single nStride APS injection or a single saline injection. The study showed a 65% improvement in the WOMAC pain score for nStride APS patients, compared with a 41% improvement for the control arm. VAS pain scores improved 49% for t...
Source: Mass Device - December 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Orthopedics zimmerbiomet Source Type: news

OA prevalence more than doubled over 15-year period
A study published online in the American Journal of Public Health examines trends in arthritis and finds that prevalence of osteoarthritis (OA) more than doubled in the United States from 1999 to 2014.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - December 24, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

The mediating role of psychological symptoms on falls risk among older adults with osteoarthritis - Mat S, Ng CT, Fadzil F, Rozalli FI, Tan MP.
The purpose of this study was to investigate the role of fear of falling (FoF) and psychological symptoms in explaining the relationship between osteoarthritis (OA) symptom severity and falls. Individuals aged ≥65 years with ≥2 falls or ≥1 injurious ... (Source: SafetyLit)
Source: SafetyLit - December 21, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Aratana's stock falls after newest pet drug treatment fails study
Aratana Therapeutics Inc.'s newest treatment for dogs failed an effectiveness study, the Leawood animal health company announced Friday. Its latest drug candidate, a fat-derived stem cell treatment, was intended to treat dogs with advanced osteoarthritis. The treatment, dubbed AT-016, had entered pivotal trials, meaning the data would be used as evidence for approval by the Food and Drug Administration. However, Aratana (Nasdaq: P ETX) did not meet the criteria to demonstrate efficacy, and between… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 18, 2017 Category: American Health Authors: Elise Reuter Source Type: news

Association Between Q-Angle and Clinical, Radiological, and Ultrasonography Findings in Knee Osteoarthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - December 17, 2017 Category: Orthopaedics Tags: Trends and Innovations Source Type: news

Best supplements for arthritis: THIS £3 pill could reduce joint pain in osteoarthritis
ARTHRITIS affects about 10 million people in the UK, including people of all ages. Taking between 50mg and 100mg of this daily supplement could help to reduce joint pain and inflammation, it ’s been claimed. (Source: Daily Express - Health)
Source: Daily Express - Health - December 15, 2017 Category: Consumer Health News Source Type: news

Osteoarthritis of the Hands
Title: Osteoarthritis of the HandsCategory: Doctor's& Expert's views on SymptomsCreated: 4/1/2002 12:00:00 AMLast Editorial Review: 12/15/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - December 15, 2017 Category: Rheumatology Source Type: news

pSivida touts pilot osteoarthritis trial for Durasert implant
pSivida (NSDQ:PSDV) touted results today from a Phase I safety and efficacy pilot trial of its sustained-release Durasert implant in patients with osteoarthritis of the knee. The company’s Durasert tech, combined with an implantable device from the Hospital for Special Surgery, was designed to continuously deliver a low dose of dexamethasone into the knee joint. Six patients with osteoarthritis of the knee were followed throughout the study for six months. Get the full story at our sister site, Drug Delivery Business News. The post pSivida touts pilot osteoarthritis trial for Durasert implant appeared first...
Source: Mass Device - December 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Implants Orthopedics Pharmaceuticals Wall Street Beat pSivida Corp. Source Type: news

Colorado biotech's knee osteoarthritis drug gets good results, stock soars
Shares in Ampio Pharmaceuticals Inc. were soaring in early Thursday trading after the Douglas County biotech reported good results from a trial of its knee osteoarthritis drug Ampion. Shares in Ampio (NYSE: AMPE) were up more than 40 percent early Thursday, rising 80 cents to $2.55. Ampio said patients in the trial experienced, on average a 53 percent decrease in pain, a 50 percent improvement in function, and a 45 percent improvement in quality of life. "We are very pleased with the positive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2017 Category: Biotechnology Authors: Ben Miller Source Type: news

Scientists Race to Regrow Lost Knee Cartilage Scientists Race to Regrow Lost Knee Cartilage
About 14 million Americans have osteoarthritis of the knees severe enough to cause pain and inflammation, according to the Arthritis Foundation, and more people are getting the condition -- also known as OA -- as they age.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 13, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

3-D knees: Memphis surgeon using innovative tech for knee replacements
Memphian Gail Blayde was suffering from end-state osteoarthritis of both of her knees when she was presented with an interesting opportunity. She could have replacements custom-made for her using a special 3-D printer. Blayde had her first knee replacement surgery, on her right knee, in June. After being "very pleased" with the results, she opted for surgery on her other knee in August. "I was on a cane, walker and wheelchair before ," Blayde said. "I'm getting back to where I can walk freely.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 13, 2017 Category: American Health Authors: Elle Perry Source Type: news

AAOS approves diagnostic and treatment criteria for osteoarthritis of the hip
(American Academy of Orthopaedic Surgeons) The American Academy of Orthopaedic Surgeons (AAOS) Board of Directors approved new Appropriate Use Criteria (AUC) for Management of Osteoarthritis of the Hip. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2017 Category: International Medicine & Public Health Source Type: news

Osteoarthritis: Doing THIS regularly could protect your joints as you age
MIDDLE aged women who do some regular form of exercise help protect their joints as they age, a new study found. (Source: Daily Express - Health)
Source: Daily Express - Health - December 6, 2017 Category: Consumer Health News Source Type: news

The effect of primary total knee arthroplasty on the incidence of falls and balance-related functions in patients with osteoarthritis - Si HB, Zeng Y, Zhong J, Zhou ZK, Lu YR, Cheng JQ, Ning N, Shen B.
This study investigated the incidence of falls, balance-related outcomes and risk factors for falls before and after primary total knee arthroplasty (TKA). Three hundr... (Source: SafetyLit)
Source: SafetyLit - December 2, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Flexion CEO: Setting Zilretta up to succeed with a history lesson
Locally acting therapies are like a religion to Flexion Therapeutics (NSDQ:FLXN) co-founder & CEO Dr. Mike Clayman, who spent decades at Eli Lilly (NYSE:LLY) with the company’s co-founder, Dr. Neil Bodick, watching promising compounds fail in late-stage trials on the heels of unanticipated safety results. “That’s part of the reason, not the whole reason but part of the reason, why the industry only has a 60% success rate in Phase III, because you can’t predict what safety’s going to look like if you’re giving a systemically-administered product that has the potent...
Source: Mass Device - December 1, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Eli Lilly & Co. Flexion Therapeutics Genzyme Corp. Source Type: news

Study Suggests Knee Replacement Be Reserved for Those More Severely Affected by Osteoarthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - December 1, 2017 Category: Orthopaedics Tags: CME Article Source Type: news

Losing weight by exercise alone does not protect knees
Losing weight through both diet and exercise is better for the knees than exercise alone Related items fromOnMedica Fibre-rich diet linked to lowered risk of painful knee osteoarthritis EU must do more to tackle obesity ‘epidemic’ Weight gain linked to cancer risk Real food and brisk daily walk best for heart health (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 28, 2017 Category: UK Health Source Type: news

FDA Warns About Serious Risks with " Medical Food " for Osteoarthritis
Used of Limbrel — a flavonoid capsule intended to manage the metabolic processes associated with osteoarthritis — is linked to potentially life-threatening conditions, the FDA warned... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 27, 2017 Category: Primary Care Source Type: news

Flavocoxid for OA Tied to Life-Threatening Health Problems Flavocoxid for OA Tied to Life-Threatening Health Problems
The FDA says several adverse events, including drug-induced liver injury and hypersensitivity pneumonitis, have been linked to flavocoxid, a medical food product marketed for osteoarthritis (OA).News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Scientists Race To Regrow Lost Knee Cartilage
Different researchers are all seeking the same goal: A way to reverse the loss of cartilage in the knee, a painful condition that causes osteoarthritis. (Source: WebMD Health)
Source: WebMD Health - November 27, 2017 Category: Consumer Health News Source Type: news

Is Outpatient Knee Replacement for You? Know Who Benefits
Treatment TermsKnee replacement surgery Author Shawn Lake Overview Duke orthopaedic surgeons now offer some people who need knee replacement surgery the option to go home a few hours after the procedure. According to Michael Bolognesi, MD, an orthopaedic surgeon at Duke who specializes in hip and knee replacement, the experience has been “overwhelmingly positive.” Content Blocks Header Who Needs Knee Replacement Surgery? ContentMore than 600,000  knee replacement surgeries  are performed each year, making it one of the most the most common  orthopaedic surgeries in the U.S. The proce...
Source: dukehealth.org: Duke Health News - November 27, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news

3D-printed implants and scaffold technology – how bioengineering innovation could treat and prevent osteoarthritis
The need for new and effective ways to treat and preventosteoarthritis has never been more urgent. Demand for total joint replacements is rising every year, and expected to double by 2030, placing a huge strain on the NHS. Meanwhile, those living with the pain of early stage osteoarthritis or at risk of developing it due to injury face limited treatment options.That’s why Arthritis Research UK is investing in innovative research dedicated to developing medical technologies which could provide an answer. By 'medical technologies' we mean cutting-edge medical devices, orthotics, implants and imaging techniques, harness...
Source: Arthritis Research UK - November 23, 2017 Category: Rheumatology Source Type: news

Arthritis Didn't Afflict Famed Clone Sheep, Experts Say
THURSDAY, Nov. 23, 2017 -- Dolly the sheep did not have early onset osteoarthritis after all, according to new research. Experts at the University of Glasgow and the University of Nottingham in the United Kingdom said their findings dispel original... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 23, 2017 Category: General Medicine Source Type: news

Radiographs of Dolly's skeleton show no signs of abnormal osteoarthritis
(University of Nottingham) Original concerns that cloning caused early-onset osteoarthritis in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.The team, who published last year's Nottingham Dollies research which showed that the 8 year-old Nottingham 'Dollies' had aged normally, have now published a radiographic assessment of the skeletons of Dolly herself, Bonnie (her naturally conceived daughter) and Megan and Morag (the first two animals to be cloned from differentiated cells). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 23, 2017 Category: International Medicine & Public Health Source Type: news

Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
ENGLEWOOD, Colo., Nov. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that a manuscript entitled: "LMWF-5A for the Treatment of Severe Osteoarthritis of the Knee: Integrated Analysis... Biopharmaceuticals, Orthopaedic Ampio Pharmaceuticals, osteoarthritis, Ampion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 22, 2017 Category: Pharmaceuticals Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: ConsultantLive)
Source: ConsultantLive - November 22, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

FDA Warns About Serious Risks with "Medical Food" for Osteoarthritis
Used of Limbrel — a flavonoid capsule intended to manage the metabolic processes associated with osteoarthritis — is linked to potentially life-threatening conditions, the FDA warned... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 21, 2017 Category: Primary Care Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

After FDA nod, Flexion launches osteoarthritis injection
Flexion Therapeutics (NSDQ:FLXN) today launched its Zilretta therapy designed to help patients manage pain associated with osteoarthritis of the knee. The Burlington, Mass.-based company’s extended-release intra-articular injection combines a commonly administered, short-acting corticosteroid with a polylactic-co-glycolic acid matrix using Flexion’s microsphere technology. Get the full story at our sister site, Drug Delivery Business News. The post After FDA nod, Flexion launches osteoarthritis injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Flexion Therapeutics Source Type: news

Osteoarthritis patients 'negatively affected by a fear of movement'
People with kneeosteoarthritis are experiencing a decreased quality of life due to a fear of movement associated with the condition. This is according to a new US study carried out by the University of North Carolina at Chapel Hill, which has indicated that this fear of movement may be causing those with osteoarthritis to lead less active lifestyles, putting them at risk of their conditions worsening. Factors affecting fear of movement For this study, a total of 350 participants taking part in a clinical trial were asked to evaluate their fear of movement, as well as providing details on their age, sex, race, education,pai...
Source: Arthritis Research UK - November 15, 2017 Category: Rheumatology Source Type: news

Drug hope for severe hand pain in osteoarthritis patients
The debilitating hand pain often experienced by osteoarthritis patients can be successfully treated with a drug normally used for epilepsy, anxiety and neuropathic pain, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - November 13, 2017 Category: Nursing Source Type: news

A personalised approach to chronic knee problems
Knee osteoarthritis is a chronic musculoskeletal disorder that affects over eight million people in the EU. The EU-funded KNEEMO project is developing a unique personalised approach to treatment and training a new generation of biomechanical specialists. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 13, 2017 Category: Research Source Type: news